Gerri Henwood

Directeur Général chez BAUDAX BIO, INC.

Profil

Gerri A. Henwood founded IBAH, Inc. in 1985, where she worked as President & Chief Executive Officer from 1985 to 1999, Auxilium Pharmaceuticals LLC in 1999, where she worked as President & Chief Executive Officer from 1999 to 2006, Societal CDMO, Inc. in 2008, where she worked as Director from 2020 to 2022, and Malvern Consulting Group, Inc. in 2006, where she worked as President from 2006 to 2013.
Ms. Henwood also currently works at Garnet BioTherapeutics, Inc., as Chief Executive Officer, Baudax Bio, Inc., as President, Chief Executive Officer & Director from 2019, LZ Therapeutics, Inc., as Director, and La Salle Academy, as Trustee.
Ms. Henwood also formerly worked at Alkermes, Inc., as Independent Director from 2011 to 2015, MAP Pharmaceuticals LLC, as Independent Director from 2004 to 2013, Tetraphase Pharmaceuticals, Inc., as Independent Director from 2015 to 2020, Smith Kline & French Laboratories Ltd., as Group Director-Marketing, Alkermes Plc, as Independent Director from 2011 to 2015, Actinium Pharmaceuticals, Inc., as Chief Development Officer from 2012 to 2013, SCP Vitalife Partners, as Venture Partner, and Neumann University, as Trustee.
Ms. Henwood received her undergraduate degree from Neumann University.

Postes actifs de Gerri Henwood

Sociétés	Poste	Début
BAUDAX BIO, INC.	Directeur Général	01/01/2019
La Salle Academy	Directeur/Membre du Conseil	-
LZ Therapeutics, Inc.	Directeur/Membre du Conseil	-
Garnet BioTherapeutics, Inc.	Directeur Général	-

Anciens postes connus de Gerri Henwood

Sociétés	Poste	Fin
SOCIETAL CDMO, INC.	Fondateur	18/01/2022
TETRAPHASE PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	01/06/2020
ALKERMES PLC	Directeur/Membre du Conseil	07/03/2015
Alkermes, Inc.	Directeur/Membre du Conseil	01/03/2015
Actinium Pharmaceuticals, Inc. /Old/	Corporate Officer/Principal	18/04/2013